ALK and neoplasm: Additional targeting explorations include TIM-3 blockade,161 a potential targetable mutation,162 targeting immune checkpoint,163 and its migration, invasion and metastasis,164 warning about the consequences of radiation,165,166 and chemotherapy, ALK-related neuroblastic tumor susceptibility, targeting c-Myc transactivation, immune modulation, prognosis, suppressor of ferroptosis, prevention, and more.167–170